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Introduction
In 2015, the United Nations adopted 17 sustainable develop-
ment goals, reflecting a commitment to end poverty in all 
forms by 2030. Among the targets of the third goal is the 
establishment of universal health coverage (UHC),1 ensuring 
“all people and communities can use the promotive, preventive, 
curative, rehabilitative and palliative health services they need, 
of sufficient quality to be effective, while also ensuring that 
the use of these services does not expose the user to financial 
hardship”.2 Achieving this requires countries to expand the 
number of health conditions covered, improve the quality of 
services, increase the number of people covered and provide 
protection against financial risk.3
Health policy decision-making is complicated, however, 
by the fact that no health policy can improve coverage, equity, 
quality and financial risk protection simultaneously and to the 
same degree.4 This forces policy-makers to confront challeng-
ing resource-allocation questions: Is it more important for 
society to cover more people, treat more conditions, improve 
equity or increase financial protection? Ideally, choosing 
among different policies (Box 1) requires knowledge about 
the population’s preferences, knowledge which may not exist.
Analytical models such as extended cost‒effectiveness 
analyses can make the health, financial and equity effects of 
policies explicit.4–8 The newest recommendations of the Second 
Panel on Cost–Effectiveness in Health and Medicine advocate 
including an impact inventory of the non-health outcomes 
of medical interventions, such as economic productivity.9,10 
However, other than simply reporting multiple outcomes, no 
method exists for decision-making that balances these many, 
and sometimes conflicting, domains.
This paper describes the development of a method for 
health policy decision-making in the absence of knowledge 
about a society’s preferences, with modifications for dealing 
with undesired outcomes. The method is an extension of stan-
dard data envelopment analysis, adapted for health policymak-
ing; it combines the costs of health policies with their effects 
on multiple disparate domains into a single rank-ordering. We 
evaluated the method by applying it to the findings of three 
previous extended cost–effectiveness analyses.
Methods
Measuring value in health
The literature of cost–effectiveness research,11 and, more re-
cently, of value-based health care12 has defined value as:
  
 = outcomecostvalue    (1)
Although theoretically attractive, operationalizing this ratio is 
difficult when there are multiple inputs and outputs.
To illustrate the concept of preference weighting we can 
consider two health-care policies: (i) training community 
health workers, which costs United States dollars (US$) 10 000, 
requires 10 faculty, averts 500 disability-adjusted life-years, 
and prevents 10 instances of catastrophic expenditure an-
nually; or (ii) training specialists, which costs US$ 100 000, 
requires 20 faculty, and averts 600 disability-adjusted life-years 
and 12 instances of catastrophic expenditure annually. Cost‒ef-
fectiveness analysis looks only at costs and health benefits. The 
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first policy costs US$ 20 per disability-
adjusted life-years averted, while the 
second policy carries an incremental 
cost‒effectiveness ratio11 of US$ 900 
disability-adjusted life-years averted. 
Decision-making is straightforward: 
if these ratios are less than society’s 
willingness to pay, the policy is deemed 
cost–effective.
This betrays an underlying assump-
tion, not consistent with reality: that 
health effects and costs are sufficient 
metrics for decision-making. Patients, 
for example, may choose health care 
based on other factors such as afford-
ability, satisfaction, distance or time. 
How people judge these trade-offs (that 
is, their underlying preference structure) 
is unknown. Furthermore, this prefer-
ence structure is likely to vary across 
patients, be difficult to assess and not 
predicted by patients’ demographics.13 
Patient-centred policy, then, must ac-
count for the fact that health effects and 
costs are valued against other inputs and 
outcomes. At the same time, laborious 
assessments of preference structures for 
every policy decision are impossible. 
Equation (1) can be extended to en-
compass more fully the examples above, 
including the domains of personnel and 
financial catastrophe, in addition to 
health and cost:
  
 
1 2
1 2
 u DALY u catexpvalue
v cost v personnel
+
=
+
(2)
The preference weight coefficients (u and 
v) formalize the trade-offs inherent in 
decision-making; that is, how important 
health and costs are relative to other 
outputs and inputs (cost‒effectiveness 
assumes u2 and v2 are zero).
Instead of attempting to determine 
the population’s values for u and v, our 
proposed method sets the preference 
weights as unknown and solves for 
them instead. To do so, it must impose 
two constraints: (i) the value of any 
policy must remain between 0 and 
1 (inclusive); and (ii) u and v must 
take some positive value. With these 
constraints in place, the analysis finds 
solutions for u and v such that the value 
of each policy is as high as possible, 
while the values for all other potential 
policies, using these same preference 
weights, meet the constraints set above. 
This allows each policy to be judged on 
its own merits.
Data envelopment analysis
To calculate value of a policy without 
specifying the relative importance of 
inputs and outputs, the analysis instead 
allows each policy to set its own prefer-
ence weights. Mathematically, we start 
with the first policy, po, out of a set of K 
total policies. po will use some amount of 
input (x) and produce some amount of 
output (y). The value of po, which we call 
θo, is a generalization of Equation (2): 
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Importantly, inputs and outputs are 
treated as having no units of measure-
ment. That is, inputs could include 
square feet of hospital space, numbers 
of nurses and costs of the policy, while 
outputs could include deaths averted, 
impacts on a country’s gross domestic 
product and measures of equity.
The constraints imposed above 
make this a linear optimization problem 
in which θo is maximized such that all 
efficiencies for all K policies are at most 
1, and no policy is allowed to put zero 
weight on any input or output:
  
 
0max
1
, 0
k k K
u v >
such that
 
(4)
A value of 1 suggests that no other policy 
is producing more outputs for a given 
set of inputs than p0. A value < 1 implies 
that po could do better (that is, other 
Box 1. Three hypothetical policy interventions that illustrate trade-offs in health policy 
decision-making 
Policy A
Policy characteristics:
• Cost US$ 175 000
• 200 deaths averted
• 40 cases of catastrophic health expenditure created
• Mildly favours richer patients
This policy improves health the most, but is mildly regressive and creates catastrophic medical 
expenditure for patients
Policy B
Policy characteristics:
• Cost US$ 150 000
• 40 deaths averted
• 20 cases of catastrophic health expenditure averted
• Mildly favours poorer patients
This policy is less regressive than Policy A and provides financial risk protection, (i.e. negative 
cases of catastrophic expenditure created) but delivers the least health benefit.
Policy C
Policy characteristics:
• Cost US$ 200 000
• 80 deaths averted
• 60 cases of catastrophic health expenditure created
• Strongly favours poorer patients
This policy is the most equitable of the three and provides a moderate amount of health 
improvement, but creates the most financial catastrophe and is the most expensive.
Choosing among these policies
Ideally, choosing among the three would require knowledge about the target population’s 
preference weights across health, financial risk protection, equity and cost. In the absence 
of such knowledge, balancing the competing outcomes is difficult, and is the subject of the 
method presented here.
US$: United States dollars.
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policies would convert its inputs into 
more outputs more efficiently).
Note that because the efficiency 
for each policy is calculated using the 
optimization, the relative importance 
weights, u and v, are recalculated for each 
policy. As a result, any inefficient policy 
can no longer be blamed on some exter-
nal imposition of weights. Unfortunately, 
because each policy sets its own weights, 
it is conceivable, and in fact likely, for 
many to appear efficient, leaving the 
policy-maker with little guidance.
Modifications for health policy
Four additional modifications are neces-
sary to adapt data envelopment analysis 
to health policy applications. The first 
modification, already done above, is 
to treat the policy itself as the object 
of analysis, as opposed to any policy-
maker, hospital or provider. This can 
be done because policies have direct 
consequences on the population’s health, 
financial well-being and equity (that 
is, they have direct outputs). Doing so 
requires decisions about cost, workforce 
training, infrastructure development 
and other inputs.
The second modification addresses 
the problem posed by multiple efficient 
policies. In real-world applications of 
Equation (4), many policies end up hav-
ing a value of 1 (the maximum), which 
does not help the policy-maker. To 
produce a rank-ordering of policies, the 
first constraint in Equation (4) must be 
relaxed: in this so-called superefficiency 
analysis θo is allowed to be larger than 
1, while values for every other policy 
remain constrained.
  
 
  
max
1 ; 
, 0
o
k k K k o
u v >
such that
(5)
θo is calculated for the first policy, 
subject to the constraint that the value 
of all other policies remain between 
0 and 1. This θ1 is recorded, and the 
cycle repeats itself for the second policy. 
When θ2 is calculated it is allowed to be 
larger than 1, but in that calculation, θ1 
is constrained. Once this calculation is 
done, θ2 is recorded, and Equation (5) is 
repeated for the third decision-making 
unit, and so on.
This relaxation of constraints begins 
to produce rank orderings of health 
policies. However, a third modifica-
tion is required. Equations (4) and (5) 
assume a constant return to scale, that 
is, that each additional unit of inputs 
(e.g. costs, personnel), will produce 
exactly the same unit of outputs as the 
one before. This is unlikely to be true in 
health. Policies that put a single surgeon 
in a previously unstaffed hospital, for ex-
ample, are likely to return a significantly 
larger health benefit than those adding a 
second surgeon to a hospital that already 
has one. Allowing variable return to 
scale requires some added calculation, 
which has been developed elsewhere.14 
Infeasibility is contravened by the Cook 
modification.15
One final modification is necessary 
to apply data envelopment analysis to 
health policy. In manufacturing, from 
which the method is derived,16 a pro-
ducer cannot produce negative numbers 
of a product. In rare cases of negative 
outputs, the standard practice is to 
scale manufacturers’ outputs such that 
negative production no longer happens. 
That is, if a factory produces, 20 units of 
a product, 20 units of that product are 
simply added to the output of all facto-
ries, such that the negatively-producing 
manufacturer now produces 0, and every 
other manufacturer produces 20 more 
than previously. Although this may be 
mathematically justified, the translation 
to health is tenuous. For example, some 
policies can improve health, but worsen 
catastrophic out-of-pocket expenses for 
patients, thereby producing negative 
financial risk protection. Linear scal-
ing would imply that such policies no 
longer produce any impoverishment, 
but that all other policies arbitrarily now 
provide even more protection against 
impoverishment. The probability that 
patients would find these two scenarios 
equivalent is low, making such scaling 
unhelpful to a decision-maker. A health-
policy-adapted framework must take 
this into account.
We therefore allowed any outcome 
to serve as both an output and an input. 
For example, in cases of negative finan-
cial risk protection (that is, increased 
catastrophic expense) the additional 
financial risk produced by a policy 
is counted as a cost (or input) to the 
analysis. When catastrophic expense is 
prevented, the financial risk protection 
is counted as an output of the analysis. 
This modification penalizes policies 
with negative outcomes by increasing 
the size of the denominator in Equa-
tion (1), thereby decreasing that policy’s 
efficiency.
Data sources and analysis
We tested our health-adapted superef-
ficiency data envelopment analysis 
method by applying it to data from 
three previously published extended 
cost‒effectiveness analyses of policy 
inteventions.4,5,8 The first example was an 
analysis of policies to increase access to 
surgery in Ethiopia in terms of the cost, 
health benefits and effects on financial 
risk protection (Table 1). The second 
example was a synthesis of different 
preventive and curative health interven-
tions from several analyses, reporting 
the cost, health benefits and financial 
Table 1. Extended cost–effectiveness analysis of policy interventions to increase access 
to surgery in rural Ethiopia
Intervention Cost, US$ No. of deaths 
averted
No. of cases of 
impoverishment 
averted
Universal public finance 945 313 22.99 360.71
Universal public finance + 
vouchers
5 516 092 58.64 2 646.68
Task-shifting 401 491 252.55 −578.43
Universal public finance + 
task-shifting
2 354 435 289.12 −231.17
Universal public finance + 
task-shifting + vouchers
9 705 724 327.51 2 646.68
Task-shifting + vouchers 3 201 492 278.06 −372.65
US$: United States dollars.
Notes: The data are from a previously published study4 and were used to test the health-adapted 
superefficiency data envelopment analysis method, producing the policy ranking shown in Table 4. As 
defined in the original paper, universal public finance refers to making surgery free at the point of care. 
Task-shifting refers to training non-surgeons to provide a limited bundle of surgical services. Vouchers refer 
to issuing patients with vouchers for the non-medical costs of care.
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risk protection of the interventions 
(Table 2). The third example looked at 
both government policy interventions 
and nongovernmental platforms for im-
proving access to surgical cancer care in 
Uganda in terms of cost, deaths averted, 
cases of impoverishment averted and 
equity (Table 3).
Since the purpose of this paper was 
not the validation of prior analyses, 
we did not repeat any of these cost‒ef-
fectiveness analyses; they were used 
as examples rather than outcomes of 
this paper. Similarly, the underlying 
assumptions in these original papers 
(for example, that health, financial risk 
protection and equity may be mutually 
exclusive) were not tested in this paper. 
They were, as with all the results used as 
examples, and were taken at face value.
We compared the results of the new 
method with two existing methods: 
traditional cost‒effectiveness analysis 
(which incorporates only costs and 
health benefits); and standard data 
envelopment analysis. Analysis was 
performed in R software, version 3.0 (R 
Foundation for Statistical Computing, 
Vienna, Austria). Institutional review 
board approval was not required, 
because the analysis used previously 
published data.
Results
Comparing related policies
Table 4 shows the results of applying 
the three decision-making tools to the 
analysis of policies to increase access to 
surgery (Table 1). Traditional cost‒ef-
fectiveness analysis would rule out 
three of the policies (universal public 
finance, task-shifting plus vouchers for 
non-medical costs and universal public 
finance plus vouchers), because they 
are dominated by other policies, that is, 
other policies are both less expensive 
and more effective. Of the remaining 
policies, a combination of universal 
public finance plus task-shifting plus 
vouchers had the least attractive cost‒
benefit ratio: over US$ 190 000 per death 
averted. Standard data envelopment 
analysis was uninformative: all except 
one policy (task-shifting plus vouchers) 
had the maximal value of 1. 
By contrast, health-adapted super-
efficiency data envelopment analysis 
allowed the policies to be ranked from 
highest (value score: 6.59) to lowest 
value (score: 0.67), incorporating both 
Table 2. Extended cost–effectiveness analysis of various unrelated preventive and 
curative health interventions in Ethiopia
Intervention Government 
expenditure, 
US$ × 1 000 
Household 
expenditure 
averted, 
US$ × 1 000
No. of 
deaths 
averted
No. of cases of 
impoverishment 
averted
Rotavirus vaccine 800 180 510 270
Pneumococcal 
vaccine
1 200 110 1 700 170
Measles vaccine 260 9 890 14
Diarrhoea treatment 50 000 26 000 3 600 40 000
Pneumonia 
treatment
31 000 15 000 4 100 23 000
Malaria treatment 670 300 410 460
Caesarean section 420 270 590 410
Tuberculosis 
treatment
6 900 4 400 2 600 6 700
Hypertension 
treatment
1 300 730 140 1 100
US$: United States dollars.
Notes: The data are from a previously published study8 and were used to test the health-adapted 
superefficiency data envelopment analysis method, producing the policy ranking shown in Table 5.
Table 3. Extended cost–effectiveness analysis of various government and 
nongovernmental interventions for delivery of surgical cancer care in Uganda
Intervention Cost, US$ 
per 100 000 
population
No. of 
deaths 
averted 
per 100 000 
population
No. of 
cases of 
impover-
ishment 
averted 
per 100 000 
population
No. of 
cases of 
catastrophic 
expense 
averted 
per 100 000 
populationa
Equity 
scorea
Universal public 
finance
3 320 3.0 0.7 4.2 −0.08
Task-shifting 301 3.2 −8.1 −34.8 −0.16
Universal public 
finance + task-
shifting
3 670 8.7 −1.8 −23.1 −0.24
Universal public 
finance + vouchers
24 470 30.7 123.8 218.6 0.24
Task-shifting + 
vouchers
13 701 18.7 18.0 57.1 −0.05
Universal public 
finance + task-
shifting + vouchers
25 009 33.6 127.2 218.6 0.23
Two-week mission 
trip
40 438 1.5 2.4 7.2 0.23
Mobile surgical unit 7 047 42.8 106.6 99.4 0.19
Cancer hospital 54 431 30.3 74.9 81.2 0.13
US$: United States dollars.
a  Equity scores were scaled from 1 (most favourable to poorer patients) to −1 (most favourable to richer 
patients).
Notes: The data were from a previously published study5 and were used to test the health-adapted 
superefficiency data envelopment analysis method, producing the policy ranking shown in Table 6. As 
defined in the original paper, universal public finance refers to making surgery free at the point of care. 
Task-shifting refers to training non-surgeons to provide a limited bundle of surgical services. Vouchers refer 
to issuing patients with vouchers for the nonmedical costs of care. Two-week surgical mission trips and the 
construction of a cancer hospital are self-explanatory. The modelled mobile surgical unit travelled around 
Uganda providing surgery at locations not served by a hospital.
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the health and the financial protective 
effects of these policies. When these ef-
fects were included in the decision, the 
combination of all three policies (uni-
versal public finance plus task-shifting 
plus vouchers) provided the best value 
for the combination of health and finan-
cial risk protection (score: 6.59). The 
next best policies were universal public 
finance alone (score: 5.84), which domi-
nated in the cost‒effectiveness analysis, 
and task-shifting alone (score: 5.38). 
Task-shifting plus vouchers, which had a 
lower value score in the traditional data 
envelopment analysis (score: 0.67) had 
the same score under health-adapted su-
perefficiency data envelopment analysis 
(score: 0.67).
Comparing unrelated policies
Table 5 demonstrates the applicability 
of the different decision-making tools 
to the evaluation of multiple, unrelated 
interventions (Table 2). This is a more 
realistic scenario than the policies in 
the first example, which all concerned 
delivery of surgical services. The second 
example adds a third output, household 
expenditures averted, to deaths averted 
and impoverishment averted. Again, 
traditional data envelopment analysis 
was not the most useful tool for deci-
sion-making because only three policies 
scored <  1 and could be ruled out (ro-
tavirus vaccination, malaria treatment 
and hypertension treatment). Similarly, 
traditional cost‒effectiveness analysis 
ruled out five of the nine policies. 
Health-adapted superefficiency 
data envelopment analysis allowed dif-
ferentiation among the policies, ranking 
them from low to high value, and would 
therefore be more useful than the other 
analysis tools for prioritizing competing 
choices. Pneumococcal vaccination had 
the highest value (score: 2.84) when all 
outcomes were considered but had the 
lowest value in traditional cost‒effective-
ness analysis (US$ 1160 per death avert-
ed). The next best interventions were 
pneumonia treatment, measles vaccine, 
diarrhoea treatment and tuberculosis 
treatment (scores: 1.79‒2.75), followed 
by caesarean section birth (score: 1.51). 
Evaluating equity
The data for the third example, an analy-
sis of policies to improve access to surgi-
cal cancer care (Table 3), also included 
two measures of financial risk protection 
but added a measure of equity. Table 6 
shows that cost‒effectiveness rules out 
all but two policies (task-shifting and 
the mobile surgical unit). Traditional 
data envelopment analysis was again 
unhelpful for decision-making; only 
one policy (universal public finance for 
surgery plus task-shifting) scored <  1.
Health-adapted superefficiency data 
envelopment analysis also ranked task-
shifting (value score: 11.0) and mobile 
surgical units (score: 4.82) the highest, 
but in addition produced a clear rank-
ing among all policies, including the 
dominated ones. With equity added to 
the equation, a decision-maker using 
health-adapted superefficiency data 
envelopment analysis would be guided 
towards task-shifting, given the results 
of the underlying extended cost‒ef-
fectiveness analysis. If this were not 
Table 4. Comparison of three decision-making tools to determine the value of policy 
interventions to increase access to surgery
Intervention Incremental  
cost–effectiveness 
ratioa
Data envelopment 
analysis score
Health-adapted 
superefficiency  
data envelopment 
analysis score
Universal public finance Dominated 1.00 5.84
Task-shifting Dominated 1.00 1.76
Universal public finance + 
task-shifting
US$ 1 590 per 
death averted
1.00 5.38
Universal public finance + 
vouchers 
US$ 53 396 per 
death averted
1.00 1.98
Task-shifting+ vouchers US$ 191 515 per 
death averted
1.00 6.59
Universal public finance + 
task-shifting + vouchers
Dominated 0.67 0.67
US$: United States dollars.
a  A policy is dominated when another policy is both cheaper and more effective.
Notes: We applied the three data analysis methods to a previously published extended cost–effectiveness 
analysis of various policies to improve access to surgery in Ethiopia (Table 1).4 Cost–effectiveness analysis 
would preclude three policies as dominated. Data envelopment analysis would not give any guidance on 
how to decide among the six proposed policies. Health-adapted superefficiency data envelopment analysis 
provides a complete ranking of policies.
Table 5. Comparison of three decision-making tools to determine the value of various 
unrelated preventive and curative health interventions 
Intervention Incremental 
 cost–effectiveness 
ratioa
Data envelop-
ment analysis 
score
Health-adapted 
superefficiency 
data envelopment 
analysis score
Rotavirus vaccine Dominated 0.46 0.46
Pneumococcal vaccine US$ 1 160 per death averted 1.00 2.84
Measles vaccine US$ 292 1.00 2.43
Diarrhoea treatment Dominated 1.00 2.36
Pneumonia treatment US$ 16 067 per death averted 1.00 2.75
Malaria treatment Dominated 0.70 0.70
Caesarean section Dominated 1.00 1.51
Tuberculosis treatment US$ 6 333 per death averted 1.00 1.79
Hypertension 
treatment
Dominated 0.88 0.88
US$: United States dollars.
a  A policy is dominated when another policy is both cheaper and more effective.
Notes: We applied the three data analysis methods to a previously published extended cost–effectiveness 
analysis of various unrelated preventive and curative interventions in Ethiopia (Table 2).8 Data envelopment 
analysis does not give any guidance on how to decide among the nine proposed policies. Under cost–
effectiveness analysis, the policy with the highest health-adapted superefficiency data envelopment analysis 
value has the worst incremental cost–effectiveness ratio. Health-adapted superefficiency data envelopment 
analysis provides a complete ranking of policies, even when the policies address different health conditions.
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feasible, or in the interim while it was 
being scaled up, mobile surgical units 
might be the best choice to deliver surgi-
cal oncology care.
Discussion
In this paper, we developed and tested 
a method for decision-making in 
health policy when the population’s 
preferences among potential outcomes 
are unknown. We found that health-
policy-adapted superefficiency data 
envelopment analysis was capable of 
incorporating multiple attributes and 
functioned better than incremental 
cost‒effectiveness ratios or traditional 
data envelopment analysis in health-
policy settings.
Since cost‒effectiveness analysis 
relies on a ratio of incremental costs over 
incremental health effects (measured 
often as disability-adjusted life-years, 
quality-adjusted life-years or absolute 
numbers of lives saved), it ignores the 
non-health effects of policies. As such, 
this common decision-making method 
does not fully represent the wishes of a 
population, a weakness that has led to 
counterintuitive results17 and, in some 
cases, an implicit prohibition against 
using ratios for decision-making alto-
gether.18
In moving towards UHC, we need 
to look at the effects of health policies 
on multiple domains, including, for 
example, health, financial well-being 
and equity. The assumptions made in 
traditional cost‒effectiveness analysis 
become unsound. As this paper shows, 
the multi-attribute value of policy pro-
posals is often categorically different 
from their cost‒effectiveness. Policies 
that are dominated under cost‒effective-
ness analysis assumptions, and therefore 
declared unworthy of further study, 
become efficient, and sometimes the 
most efficient, with multi-attribute de-
cision-making. Our method produces a 
rank-ordering of policies, allowing more 
comprehensive decisions to be made.
Given that between 20% and 40% 
of health spending globally is wasted 
because of inefficiency,19 health-adapted 
superefficiency data envelopment analy-
sis can provide valuable information to 
increase efficiency. Data envelopment 
analysis has been used to evaluate health-
care delivery by facilities in various 
low- and middle-income countries20–24 
and management of chronic disease in 
American states,25 and even as a way to 
evaluate the relative merit of scientific re-
search projects.26 Our new method, how-
ever, allows data envelopment analysis to 
be applied to policies and to be modified 
for health-specific contexts.
Our new method has its limitations. 
Value, as defined by this method, can 
only be a proxy for decision-making. 
The method does not avoid the need 
for formal evaluations of population 
preferences over health improvement, 
financial risk protection and equity. 
These evaluations are difficult to per-
form, however, and this new method 
of analysis allows health policy choices 
to be made in the absence of quantita-
tive evidence on patient preferences. 
In addition, only quantitative inputs 
and outputs can be considered in this 
new method. Non-quantitative factors 
which may be important to a policy-
maker, such as political will, must either 
be quantified or be excluded from the 
analysis. Finally, it is not a method for 
policy evaluation, but for decision-mak-
ing after evaluation. Cost‒effectiveness 
analyses, extended and otherwise, can 
be employed to predict the outcomes of 
potential policies, but cannot by them-
selves guide the policy-maker in how to 
choose given these outcomes. We de-
veloped this new method to move from 
evaluation to decision-making. Since no 
single score can dictate policymaking, 
our method can be used to help guide 
a policy-maker as to the relative value 
of a proposed policy. Other, competing 
priorities and political realities must be 
balanced with these results.
Despite these weaknesses, the pro-
posed new method has many strengths 
for health policy decision-making. First, 
it allows a holistic, multidimensional 
evaluation of health policies. As health 
policies assessments begin to incor-
porate all three aspects of the UHC 
framework,9 the method will permit 
multi-attribute decision-making that 
can incorporate any quantifiable at-
tribute or determinant of health. The 
method is not limited to health, equity 
and financial risk protection, as in the 
examples presented here.
Second, the analysis is relatively 
easy to perform. We used R, a free and 
publicly available statistical software, 
but other software programs include 
add-in modules for data envelopment 
analysis. To facilitate use of our method, 
we have developed a stand-alone, free, 
web-based module (available at: http://
markshrime.com/research-tools/).
Table 6. Comparison of three decision-making tools to determine the value of various 
government and nongovernmental interventions for improving the delivery of 
surgical oncology services, when equity is added
Intervention Incremental  
cost–effectiveness 
ratioa
Data envelopment 
analysis  
score
Health-adapted 
superefficiency 
data envelopment 
analysis score
Universal public finance Dominated 1.00 2.12
Task-shifting US$ 94 per death 
averted
1.00 11.07
Universal public finance + 
task-shifting
Dominated 0.89 0.89
Universal public finance + 
vouchers
Dominated 1.00 2.08
Task-shifting+ vouchers Dominated 1.00 1.00
Universal public finance + 
task-shifting + vouchers
Dominated 1.00 2.05
Two-week mission trip Dominated 1.00 1.00
Mobile surgical unit US$ 99 per death 
averted
1.00 4.82
Cancer hospital Dominated 1.00 1.00
US$: United States dollars.
a  A policy is dominated when another policy is both cheaper and more effective.
Notes: We applied the three data analysis methods to a previously published cost–effectiveness analysis 
of government policies and nongovernmental platforms for improving the delivery of surgical oncology 
services in Uganda (Table 3).5 Data envelopment analysis does not give any guidance on how to decide 
among the six proposed policies. Cost–effectiveness analysis and health-adapted superefficiency data 
envelopment analysis favour similar policies. Health-adapted superefficiency data envelopment analysis, 
however, offers a ranking of policies that appear dominated by cost–effectiveness analysis alone.
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Finally, the new method does not 
require a judgement about the relative 
importance of each policy domain. 
Population-level preference studies are 
needed to quantify the how much a coun-
try’s population values health protection, 
cost, equity and financial risk protection. 
Until then, our method of analysis offers 
guidance for policy-makers.
In conclusion, health-adapted su-
perefficiency data envelopment analy-
sis is an adaptable tool for decision-
making in the sustainable development 
era. The method is a formalization 
of the value model in health, flexibly 
incorporating comprehensive factors 
within both outcome and input do-
mains. As such, the method can be used 
in place of cost‒effectiveness analysis 
and other ratio methods for decision-
making. This paper demonstrates that 
this method is not only feasible, but by 
providing a rank order of policies, more 
aptly represents the multidimensional 
decision-making that faces policy-
makers daily. ■
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صخلم
ةيلماعلا ةيحصلا ةيطغتلا في رارقلا ذاتخا ةيلمعل ةيحصلا مظنلا بسح ل َّدعلما تانايبلا ةيطغت ليلتح
 ةميقل  يعوضوم مييقت  ءارجإ حيتت  ةقيرط رابتخاو ريوطت ضرغلا
.تلااجلما نم ديدعلا في ةيحص ةسايس يأ
 لىع نيدمتعلما رارقلا  عانص ةدعاسلم بولسأ ريوطتب انمق ةقيرطلا
 رايتخلال عمتجلما تايلضفأ لوح ةيفاك يرغ ةفرعمو ةدودمح دراوم
 نوكت ام اًنايحأ يتلاو – ةئفاكتلما يرغ راثلآا تاذ تاسايسلا ينب ام
 يذلا  بولسلأا  لمعيو  .ةددعتلما  تلاصحلما  لىع  –  ةضراعتم
 ثيحب  تانايبلا  ةيطغتل  سيايقلا  ليلحتلا  قاطن  دم  لىع  همدقن
 ةتجانلا  تلاصحلما ددعت لثم ،ةيحصلا  ةسايسلا  عئاقو عم لماعتي
 حئاشرلا تايلضفأ لوح تامولعلما لقنو ،ةيبلس تلاصمح ءوشنو
 تلايدعت ةعبرأ انيرجأ دقو .تلاصحلما كلتب قلعتي مايف ةيناكسلا
 اهتفصب اتهاذ ةسايسلا  جلاع :ليي مايف  لثمتت  سيايقلا  ليلحتلا  لىع
 يبتارت  فينصت  جاتنإب  بولسلأل  حماسلا  )ب(و  ،ليلحتلل  فده
 تايطعمو  جتان  ةباثمب  ةلصمح  رابتعاب  حماسلا  )ـج(و  ،تاسايسلل
 دقو .مجلحا ةيرغتم دئاوع باستحاب حماسلا )د(و ،تقولا سفن في
 ضيالما  في  اهشرن  قبس  تلايلتح  ةثلاث  ءوض  في  بولسلأا  انبرتخا
 لخدلا  تايوتسم  اهدوست  يتلا  تائيبلا  في  ةيحصلا  تاسايسلل
.ةضفخنلما
 تلايلحتلا  لىع  انبناج  نم  حترقلما  بولسلأا  قيبطت  دنع  جئاتنلا
 نم  لضفأ  ًءادأ  ديدلجا  بولسلأا  ءادلأا  اذه  ققح  دقف  ،ةقباسلا
 ةيطغتل  سيايقلا  ليلحتلاو  ةفلكتلا  ةيلاعفل  يديلقتلا  ليلحتلا
 رثكلأا  تلاخدتلا  دديح  نأ  لّدعلما  ليلحتلل  نكمأو  .تانايبلا
 تعضخ يتلا تاسايسلا نم ةعوممج يأ ينب نم ةسايسلا في ةيلاعف
.تلاخدتلا عيملج يبتارت فينصت ميدقت هنكمأ ماك ،مييقتلل
 ةيحصلا مظنلا بسح ل َّدعلما تانايبلا ةيطغت ليلتح حيتي جاتنتسلاا
 ةيلمع في يّمكلا سايقلل لباق ةحصلل د ِّدمح وأ ةيصاخ يأ ينمضت
 بايغ  في  هنكمي  ماك  ،ليلحتلا  اذه  ءارجإ  لهسلا  نمو  .ةيباسح
 مدقي  نأ  تاعمتجلما  دحأ  في  ةدئاسلا  تايلضفلأا  لوح  ةلدلأا
 صرع في ةيحصلا تاسايسلا نأشب رارقلا ذاتخا ةيلمعل ًلاماش اًبولسأ
.ةمادتسلما ةيمنتلا
摘要
用于全球卫生覆盖情况决策制定的适用于卫生系统的数据包络分析
目的 开发并测试一种可客观评估多领域任意卫生政策
价值的方法。
方法 我们开发了一种方法，在资源有限且对社会偏好
缺乏足够了解的情况下，协助决策者在对多个结果有
不平等（时而相反）效果的政策间做出选择。我们的
方法拓展了标准的数据包络分析以解决卫生政策的现
实问题，例如产生多种相反结果、缺乏针对这些结果
的群体偏好信息。我们对标准分析作了 4 次修改：(i) 将
政策本身视为分析对象 ；(ii) 可采用该方法为政策排
序 ；(iii) 任何结果既可作为输出信息 , 又可作为输入信
息 ；和 (iv) 可测量浮动回报。我们采用之前发布的三
种低收入国家卫生政策分析来测试该方法。
结果 我们的新方法用于先前分析时，比传统成本效益
分析和标准数据包络分析的效果更好。调整后的分析
可从任何一组已评估的政策中确定最有效的政策干预
措施，并能将所有干预措施排序。
结论 适用于卫生系统的数据包络分析使任何卫生的度
量类属性或决定因素均可纳入计算。该分析易于进行，
在可持续发展时代，在缺乏社会对多政策结果偏好证
据的条件下，它能为卫生政策决策制定提供一种综合
方法。 
Résumé 
Analyse de l’enveloppement de données adaptée au système de santé pour la prise de décision concernant la couverture 
sanitaire universelle
Objectif Développer et tester une méthode permettant d’évaluer 
objectivement la valeur de toute politique sanitaire dans de multiples 
domaines.
Méthodes Nous avons développé une méthode pour aider les 
décideurs qui possèdent des ressources limitées et des connaissances 
insuffisantes concernant les préférences d’une société à choisir entre des 
politiques ayant des effets inégaux, et parfois opposés, sur de multiples 
résultats. Notre méthode élargit l’analyse standard de l’enveloppement 
de données pour tenir compte des réalités d’une politique sanitaire, 
et notamment de résultats multiples et négatifs et d’un manque 
d’informations concernant les préférences d’une population à l’égard 
de ces résultats. Nous avons apporté quatre modifications à l’analyse 
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standard: (i) nous avons pris la politique elle-même comme objet 
d’analyse; (ii) nous avons fait en sorte que la méthode permette de 
classer les politiques; (iii) nous avons veillé à ce que chaque résultat serve 
à la fois d’entrée et de sortie; et (iv) nous avons prévu un rendement 
d’échelle variable. Nous avons testé la méthode par rapport à trois 
analyses précédemment publiées de politiques sanitaires dans des 
pays à faibles revenus.
Résultats Appliquée aux précédentes analyses, notre nouvelle méthode 
a donné de meilleurs résultats qu’une traditionnelle analyse coût-
efficacité et qu’une analyse standard de l’enveloppement de données. 
Cette analyse adaptée a permis de repérer les interventions les plus 
efficaces parmi un ensemble de politiques évaluées et d’établir un 
classement de toutes les interventions.
Conclusion L’analyse de l’enveloppement de données adaptée au 
système de santé permet d’inclure dans un calcul toute caractéristique 
ou tout déterminant quantifiable de la santé. Cette analyse est facile à 
réaliser et, en l’absence de données concernant les préférences d’une 
société parmi plusieurs résultats de politique, elle fournit une méthode 
complète pour la prise de décision en matière de politique sanitaire à 
l’ère du développement durable. 
Резюме
Анализ охвата данных для принятия решений в области всеобщего охвата медико-санитарными 
услугами, адаптированный к системе здравоохранения
Цель Разработать и протестировать метод, который позволил бы 
объективно оценивать значение любой политики в различных 
сферах деятельности в области здравоохранения.
Методы Авторы разработали метод, содействующий принятию 
решений при выборе между политиками с неравными и порой 
противоположными последствиями уполномоченными лицами 
в условиях ограниченных ресурсов и недостаточных знаний 
о предпочтениях общества. Этот метод позволяет расширить 
применение стандартного анализа охвата данных для учета 
реалий политики здравоохранения, таких как многочисленные 
и неблагоприятные последствия, а также отсутствие информации 
об отношении населения к этим последствиям. Авторы внесли 
четыре изменения в стандартный анализ: (i) рассмотрение 
самой политики как объекта анализа; (ii) включение в метод 
возможности проведения ранжирования политики; (iii) включение 
возможности для любого последствия служить в качестве как 
исходных данных, так и результатов; (iv) включение возможности 
переменного эффекта масштабирования. Авторы протестировали 
этот метод на основе трех ранее опубликованных анализов 
политики здравоохранения в условиях низкого уровня дохода.
Результаты При применении на основе предыдущего анализа 
новый метод продемонстрировал лучшие результаты, чем 
традиционный анализ экономической эффективности и 
стандартный анализ охвата данных. Адаптированный анализ 
способен определить наиболее эффективные политические 
меры среди любого набора оцениваемых стратегий и может 
обеспечить ранжирование всех мер.
Вывод Анализ охвата данных, адаптированный к системе 
здравоохранения, позволяет включать в расчет любой 
количественный атрибут или детерминант здоровья. Такой 
анализ прост в осуществлении и при отсутствии информации 
об отношении общества к нескольким последствиям политики 
может обеспечить комплексный метод принятия решений в 
области здравоохранения в эпоху устойчивого развития.
Resumen
Análisis envolvente de datos adaptados al sistema de salud para la toma de decisiones en la cobertura universal de salud
Objetivo Desarrollar y probar un método que permita una evaluación 
objetiva del valor de cualquier política de salud en múltiples dominios.
Métodos Se desarrolló un método para ayudar a los responsables de la 
toma de decisiones con recursos limitados y conocimientos insuficientes 
sobre las preferencias de una sociedad para elegir entre políticas de 
efectos desiguales, y en ocasiones opuestos, en resultados múltiples. El 
método amplía el análisis envolvente de datos estándar para abordar 
las realidades de la política de salud, como los resultados múltiples y 
adversos y la falta de información sobre las preferencias de la población 
con respecto a dichos resultados. Se realizaron cuatro modificaciones 
al análisis estándar: (i) tratar la política en sí misma como el objeto de 
análisis; (ii) permitir que el método produzca un orden jerárquico de las 
políticas; (iii) permitir que cualquier resultado sirva como entrada y salida; 
y (iv) permitir el rendimiento variable a escala. Se probó el método en 
comparación con tres análisis publicados anteriormente de políticas de 
salud en entornos de bajos ingresos.
Resultados Cuando se aplicó a análisis previos, el nuevo método 
funcionó mejor que el análisis tradicional de coste y efectividad y que 
el análisis estándar envolvente de datos. El análisis adaptado identificó 
las intervenciones de políticas más eficaces de entre un conjunto de 
políticas evaluadas y proporcionó un orden jerárquico de todas las 
intervenciones.
Conclusión El análisis envolvente de datos adaptado al sistema de 
salud permite incluir cualquier atributo o determinante de salud 
cuantificable en un cálculo. Es fácil de realizar y, a falta de evidencia 
sobre las preferencias de una sociedad entre múltiples resultados de 
una política, proporciona un método integral para la toma de decisiones 
sobre políticas de salud en la era del desarrollo sostenible.
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